GAFFI calls together experts in Lima to formulate new thinking on fungal disease management in Latin America

Posted by & filed under Uncategorized.

July 1st 2020 15:00 BST (GMT+1) For Spanish version click here Briefing webinar: https://us02web.zoom.us/j/82914301088 For further details of the briefing visit ECMM website September 3-5th over 60 fungal disease experts from Argentina, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama, Paraguay, Peru, Uruguay and Venezuela convened in… Read more »

GAFFI convoca a un grupo de expertos en Lima para afrontar la enfermedad fúngica en Latinoamérica

Posted by & filed under Uncategorized.

July 1st 2020 15:00 BST (GMT+1) For English version click here Briefing webinar: https://us02web.zoom.us/j/82914301088 Para más detalles de la sesión informativa, visite el sitio web de ECMM Del 3 al 5 de septiembre de 2019, más de 60 expertos en enfermedades fúngicas de Argentina, Brasil, Chile, Colombia, Costa Rica, Cuba, República Dominicana, Ecuador, El Salvador,… Read more »

2019 GAFFI Annual Report issued with major progress on health systems and major mycology diagnostic network in India

Posted by & filed under Uncategorized.

2019 was a pivotal year for GAFFI’s efforts  in 3 meaningful ways: 1) The first publication from its diagnostic program for HIV patients in Guatemala was published, 2) The world’s first Health System meeting on Fungal Diseases was held for Latin America in Lima, Peru and 3) The Indian government agreed to set up a state-wide… Read more »

GAFFI Ambassadors shine light on decades of mycetoma in Senegal and Uganda

Posted by & filed under Uncategorized.

Mycetoma is a chronic granulomatous deep mycosis that causes debilitating lesions, caused by fungal or bacterial implantation through the skin. In Uganda, Richard Kwizera, Dr Felix Bongomin and colleagues in Kampala published a 69 year retrospective study of all biopsy reports produced by the Pathology Reference Laboratory at Makerere University from 1950 to 2019 (249… Read more »

How common is chronic pulmonary histoplasmosis? No one knows, but it is likely global and grossly under-diagnosed

Posted by & filed under Uncategorized.

First described in in 1948 and acknowledged as a separate clinical entity in 1953, many patients with chronic pulmonary histoplasmosis (CPH) languished in US tuberculosis sanatoriums, until picked out in the 1950’s. In one sanatorium in Missouri, 7.2% of ‘TB patients’ actually had CPH. In a review just published in Open Forum Infectious Diseases, Jacob… Read more »

On World Tuberculosis Day, remember TB-like fungal infections and co-infection of TB and Aspergillus

Posted by & filed under Uncategorized.

  Several lung fungal infections can be mistaken for TB – histoplasmosis, aspergillosis, coccidioidomycosis and paracoccidioidomycosis.  Antibody testing and fungal culture of sputum are the means of establishing the diagnosis. The number of incident cases of these fungal infections varies substantially by region and country and the rate of misdiagnosis of TB-like fungal infections is not… Read more »

Neglected, market failures, public health failures

Posted by & filed under Uncategorized.

  Writing in PLoS Neglected Tropical Diseases, Marcio Rodrigues and Joshua Nosanchuk highlight the numerous reasons why fungal diseases are so neglected. They point to a science failure – including inadequate funding. They detail research funding for different diseases by numbers of deaths: malaria $1,315 , tuberculosis $334, diarrhoeal diseases $276, compared with $31 for… Read more »

World’s first lateral flow assay for Histoplasma antigen launched

Posted by & filed under Uncategorized.

In a ground-breaking development for patients with AIDS, the world’s first lateral flow assay able to detect Histoplasma antigen has been launched by MiraVista Diagnostics, based in Indianapolis, USA. Diego Cáceres and colleagues at the Centers for Disease Control and Prevention (CDC) independently evaluated the new LFA in serum samples from patients and controls in… Read more »

Candida bloodstream infection in the USA

Posted by & filed under Uncategorized.

A recent CDC Morbidity & Mortality Weekly Report estimated the incidence of candidaemia in the US at around 9/100,000 which equates to >28,000 cases annually, with an overall mortality of 25%. 10% of cases are in IV drug abusers, 33% in diabetics and 17% in cancer patients.